PROTAC IRAK4 degrader-8
CAT:
804-HY-153673
Size:
Inquire
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

PROTAC IRAK4 degrader-8
- CAS Number: 2911615-06-8
- UNSPSC Description: PROTAC IRAK4 degrader-8 (Compound 2) is a PROTAC IRAK4 degrader (IC50: 15.5 nM). PROTAC IRAK4 degrader-8 degrades IRAK4 in THP-1 cells (DC50: 1.8 nM)。PROTAC IRAK4 degrader-8 also inhibits L-6 production in human whole blood and LPS-induced human PBMC cells, with IC50s of 246 nM and 2.2 nM respectively[1].
- Target Antigen: IRAK; PROTACs
- Type: Reference compound
- Related Pathways: Immunology/Inflammation;PROTAC
- Applications: Cancer-Kinase/protease
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/protac-irak4-degrader-8.html
- Solubility: 10 mM in DMSO
- Smiles: O=C(C(C=C1)=CC(N(CCC2=O)C(N2)=O)=C1Cl)N3CCC(CCN4C[C@H]5CC[C@H](N(N=C6C(F)F)C=C6NC(C7=C(N=C(N8[C@](CO9)([H])C[C@]9([H])C8)C=C%10)N%10N=C7)=O)CC5)(CC4)CC3
- Molecular Weight: 874.38
- References & Citations: [1]Ye Z, et al. Preparation of (pyrazolyl)pyrazolo[1,5-a]pyrimidinyl carboxamide derivatives as IRAK4 degrading agents and its applications. China, CN115710274 A. 2023-02-24.|[2]Ye Zhengqing. IRAK4 degradation agent, preparation method and application thereof. Patent. CN115710274.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported